Pioneering DMT Trial Aims to Combat Alcohol Addiction

GB
Published:

A groundbreaking clinical trial is underway at University College London (UCL) testing the psychedelic substance dimethyltryptamine (DMT) as a potential treatment for alcohol addiction. DMT is the active component in ayahuasca, a traditional hallucinogenic brew utilized in healing ceremonies by Indigenous groups in the Amazon for centuries.

Researchers are investigating whether a single dose of this powerful psychedelic can assist hazardous drinkers in reducing their alcohol consumption. Current therapies for alcohol addiction often have limited effectiveness, with studies showing that around 50% of individuals relapse within three months after treatment.

Professor Ravi Das, who is co-leading the trial, emphasized the urgent need for alternative treatment approaches, noting that the methods for addressing alcohol addiction have remained largely unchanged for decades. "To the extent that DMT might provide a more effective treatment approach, it is worth exploring," he stated.

The trial, which involves 120 participants, aims to measure the effects of DMT through advanced brain imaging techniques. Participants will receive an intravenous dose of the drug, which induces strong psychoactive effects lasting about 15 minutes, while a control group is given a placebo. The study also focuses on reactivating participants’ alcohol-related memories to evaluate whether the DMT can disrupt these patterns and lower their desire to drink.

Initial feedback from volunteers indicates that while the experience is profound, it is not one they would seek for recreational use. UCL researchers believe DMT may facilitate changes in the brain's reward system, which is often hijacked by excessive alcohol consumption.

There is ongoing recruitment for participants, who must be regular drinkers aged between 21 and 65 without a formal alcohol use disorder diagnosis. Should the trial prove successful, it may lead to further clinical studies exploring DMT's potential as an effective treatment for alcohol addiction.

Weekly Newsletter

News summary by melangenews

Loading...

More from United Kingdom

UK Woman Exposes Yoga Center's Exploitative Practices in Shocking Report

A woman from Oxfordshire has revealed her harrowing experience at the Tara Yoga Centre in London, alleging it operated as a front for a sex cult led by Gregorian Bivolaru, who faces multiple criminal charges. According to a report by The Sun, the woman, who sought spiritual healing, became ensnared in a sex trafficking ring masquerading as a yoga institution. The woman recounted being invited to a retreat where sexual activities were promoted under the guise of spiritual awakening. She described disturbing encounters with Bivolaru, where she was led to believe that sexual relations with him would facilitate enlightenment. This alarming narrative surfaced as Bivolaru was arrested by French police in November 2023 on serious charges including human trafficking and rape. During the raid, authorities rescued 58 women from poor living conditions. The Tara Yoga Centre, which promotes Bivolaru's teachings, is part of the Movement for Spiritual Integration into the Absolute, operating in the UK and 28 other countries. The woman's testimony highlights concerns over exploitation disguised as spirituality within such organizations.
GB

Scientists Near Breakthrough in Lab-Grown Eggs and Sperm Technology

Researchers in the UK are on the verge of creating eggs and sperm through in-vitro gametogenesis (IVG), a technique that could revolutionize reproduction and allow single individuals and same-sex couples to have biological children, according to a report from the Human Fertilisation and Embryology Authority (HFEA) released on January 30, 2025. The process involves generating gametes from skin or stem cells, potentially making it feasible for children to be born using lab-produced sperm and eggs within the next decade. Experts note that while this advancement could alleviate age-related infertility issues, it also raises significant ethical and medical risks. Concerns about genetic screening and the possibility of creating multiple embryos have led the HFEA to urge caution and recommend legal and ethical regulations before the technology is implemented. There are fears that such advancements could inadvertently lead to eugenics practices by allowing parents to select embryos based on desired traits. As discussions continue, the technique has not yet been made available as a medical treatment. Legal changes from the British Parliament will ultimately determine its future application.
GB

UK Government Moves to Ban Bee-Killing Pesticides Amid Ecological Crisis

The UK government is taking steps to ban three neonicotinoids—clothianidin, imidacloprid, and thiamethoxam—set to address severe threats to bee populations, according to multiple reports. This decision follows scrutiny from the Office for Environmental Protection regarding the emergency use of thiamethoxam, which has been permitted annually since 2021 despite its harmful impact on pollinators, reported The Guardian. Ecologist Dave Goulson from the University of Sussex emphasized the dangers of these pesticides, stating that "one teaspoon is enough to deliver a lethal dose to 1.25 billion honeybees." He noted that these neurotoxins not only jeopardize bees but also other insects and organisms dependent on them. The proposed ban is a response to the declining pollinator populations critical for crop production. Emma Hardy, the Environment Minister, expressed the necessity of protecting these insects, stating that maintaining a "healthy environment is vital to our food and economic security." Advocates have called for a comprehensive national pesticide plan to ensure stronger regulations moving forward.
GB